BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND TET2, Q6N021, MGC125715, KIAA1546, FLJ20032, ENSG00000168769, 54790
22 results:

  • 1. Allosterically inhibited PFKL via prostaglandin E2 withholds glucose metabolism and ovarian cancer invasiveness.
    Chen S; Wu Y; Gao Y; Wu C; Wang Y; Hou C; Ren M; Zhang S; Zhu Q; Zhang J; Yao Y; Huang M; Qi YB; Liu XS; Horng T; Wang H; Ye D; Zhu Z; Zhao S; Fan G
    Cell Rep; 2023 Oct; 42(10):113246. PubMed ID: 37831605
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Aberrant epigenetic regulation of FZD3 by tet2 is involved in ovarian cancer cell resistance to cisplatin.
    Zhu L; Zhou Q
    J Chemother; 2024 Apr; 36(2):143-155. PubMed ID: 37300277
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Genomic analysis of familial pancreatic cancers and intraductal papillary mucinous neoplasms: A cross-sectional study.
    Abe K; Kitago M; Kosaki K; Yamada M; Iwasaki E; Kawasaki S; Mizukami K; Momozawa Y; Terao C; Yagi H; Abe Y; Hasegawa Y; Hori S; Tanaka M; Nakano Y; Kitagawa Y
    Cancer Sci; 2022 May; 113(5):1821-1829. PubMed ID: 35238112
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Clonal Hematopoiesis-Associated Gene Mutations in a Clinical Cohort of 448 Patients With Ovarian cancer.
    Weber-Lassalle K; Ernst C; Reuss A; Möllenhoff K; Baumann K; Jackisch C; Hauke J; Dietrich D; Borde J; Park-Simon TW; Hanker L; Prieske K; Schmidt S; Weber-Lassalle N; Pohl-Rescigno E; Kommoss S; Marmé F; Heitz F; Stingl JC; Schmutzler RK; Harter P; Hahnen E
    J Natl Cancer Inst; 2022 Apr; 114(4):565-570. PubMed ID: 34963005
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. INI1-Deficient Thyroid Carcinoma is an Aggressive Disease with Epithelioid and Rhabdoid Phenotype. A Case Report, Survey of INI1 Expression in Thyroid Lesions and Literature Review.
    Liu Z; Seshadri M; Gupta V; Papanicolau-Sengos A; Merzianu M
    Head Neck Pathol; 2021 Dec; 15(4):1246-1252. PubMed ID: 34057693
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Thyroid MALT lymphoma: self-harm to gain potential T-cell help.
    Wu F; Watanabe N; Tzioni MM; Akarca A; Zhang C; Li Y; Chen Z; Cucco F; Carmell N; Noh JY; Ito K; Dobson R; Moody S; Yao W; Zhang W; Liu W; Liu H; Okosun J; Chott A; Bi Y; Chuang SS; Raderer M; Li JY; Marafioti T; Du MQ
    Leukemia; 2021 Dec; 35(12):3497-3508. PubMed ID: 34021249
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. tet2 Drives 5hmc Marking of GATA6 and Epigenetically Defines Pancreatic Ductal Adenocarcinoma Transcriptional Subtypes.
    Eyres M; Lanfredini S; Xu H; Burns A; Blake A; Willenbrock F; Goldin R; Hughes D; Hughes S; Thapa A; Vavoulis D; Hubert A; D'Costa Z; Sabbagh A; Abraham AG; Blancher C; Jones S; Verrill C; Silva M; Soonawalla Z; Maughan T; Schuh A; Mukherjee S; O'Neill E
    Gastroenterology; 2021 Aug; 161(2):653-668.e16. PubMed ID: 33915173
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Bcl-2-negative IGH-BCL2 translocation-negative follicular lymphoma of the thyroid differs genetically and epigenetically from Bcl-2-positive IGH-BCL2 translocation-positive follicular lymphoma.
    Hamamoto Y; Kukita Y; Kitamura M; Kurashige M; Masaie H; Fuji S; Ishikawa J; Honma K; Wakasa T; Hanamoto H; Hirokawa M; Suzuki A; Morii E; Nakatsuka SI
    Histopathology; 2021 Oct; 79(4):521-532. PubMed ID: 33829512
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Differential expression of DNA methyltransferases and demethylases among the various testicular germ cell tumor subtypes.
    Lobo J; Guimarães R; Miranda-Gonçalves V; Monteiro-Reis S; Cantante M; Antunes L; Braga I; Maurício J; Looijenga LH; Jerónimo C; Henrique R
    Epigenomics; 2020 Sep; 12(18):1579-1592. PubMed ID: 32957806
    [No Abstract]    [Full Text] [Related]  

  • 10. tet2 directs mammary luminal cell differentiation and endocrine response.
    Kim MR; Wu MJ; Zhang Y; Yang JY; Chang CJ
    Nat Commun; 2020 Sep; 11(1):4642. PubMed ID: 32934200
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Degradation of 5hmC-marked stalled replication forks by APE1 causes genomic instability.
    Kharat SS; Ding X; Swaminathan D; Suresh A; Singh M; Sengodan SK; Burkett S; Marks H; Pamala C; He Y; Fox SD; Buehler EC; Muegge K; Martin SE; Sharan SK
    Sci Signal; 2020 Aug; 13(645):. PubMed ID: 32817374
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Changes in DNA 5-Hydroxymethylcytosine Levels and the Underlying Mechanism in Non-functioning Pituitary Adenomas.
    Xu Y; Niu Y; Deng K; Pan H; Feng F; Gong F; Tong WM; Chen S; Lu L; Wang R; You H; Yao Y; Zhu H
    Front Endocrinol (Lausanne); 2020; 11():361. PubMed ID: 32774324
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Alterations of regulatory factors and DNA methylation pattern in thyroid cancer.
    Iancu IV; Botezatu A; Plesa A; Huica I; Fudulu A; Albulescu A; Bostan M; Mihaila M; Grancea C; Manda DA; Dobrescu R; Vladoiu SV; Anton G; Badiu CV
    Cancer Biomark; 2020; 28(2):255-268. PubMed ID: 32390600
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Demethylation Status of Somatic DNA Extracted From Pituitary Neuroendocrine Tumors Indicates Proliferative Behavior.
    Szabó B; Németh K; Mészáros K; Szücs N; Czirják S; Reiniger L; Rajnai H; Krencz I; Karászi K; Krokker L; Patócs A; Butz H
    J Clin Endocrinol Metab; 2020 Jun; 105(6):. PubMed ID: 32232382
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Genomic profiling of primary and recurrent adult granulosa cell tumors of the ovary.
    Da Cruz Paula A; da Silva EM; Segura SE; Pareja F; Bi R; Selenica P; Kim SH; Ferrando L; Vahdatinia M; Soslow RA; Vidal A; Gatius S; Przybycin CG; Abu-Rustum NR; Matias-Guiu X; Rubin BP; Reis-Filho JS; DeLair DF; Weigelt B
    Mod Pathol; 2020 Aug; 33(8):1606-1617. PubMed ID: 32203090
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Novel
    Moody S; Thompson JS; Chuang SS; Liu H; Raderer M; Vassiliou G; Wlodarska I; Wu F; Cogliatti S; Robson A; Ashton-Key M; Bi Y; Goodlad J; Du MQ
    Haematologica; 2018 Aug; 103(8):1329-1336. PubMed ID: 29674500
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Genomic landscape of ovarian clear cell carcinoma via whole exome sequencing.
    Kim SI; Lee JW; Lee M; Kim HS; Chung HH; Kim JW; Park NH; Song YS; Seo JS
    Gynecol Oncol; 2018 Feb; 148(2):375-382. PubMed ID: 29233531
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. A role for
    Barazeghi E; Gill AJ; Sidhu S; Norlén O; Dina R; Palazzo FF; Hellman P; Stålberg P; Westin G
    Endocr Relat Cancer; 2017 Jul; 24(7):329-338. PubMed ID: 28642344
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Genomic characteristics of pancreatic squamous cell carcinoma, an investigation by using high throughput sequencing after in-solution hybrid capture.
    Xu MD; Liu SL; Feng YZ; Liu Q; Shen M; Zhi Q; Liu Z; Gu DM; Yu J; Shou LM; Gong FR; Zhu Q; Duan W; Chen K; Zhang J; Wu MY; Tao M; Li W
    Oncotarget; 2017 Feb; 8(9):14620-14635. PubMed ID: 28099906
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Identification of Novel Oncogenic Mutations in Thyroid cancer.
    Pitt SC; Hernandez RA; Nehs MA; Gawande AA; Moore FD; Ruan DT; Cho NL
    J Am Coll Surg; 2016 Jun; 222(6):1036-1043.e2. PubMed ID: 27010584
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.